Entry Detail



General Information

Database ID:exR0090131
RNA Name:hsa-miR-541-3p
RNA Type:miRNA
Chromosome:chr14
Starnd:+
Coordinate:
Start Site(bp):101064548End Site(bp):101064569
External Links:hsa-miR-541-3p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
REPIN1
chr7
150368189
150374044
+
HOXD11
chr2
176104216
176109754
+
LY6E
chr8
143017982
143023832
+
FASN
chr17
82078338
82098294
-
M6PR
chr12
8940361
8949761
-
TOM1L2
chr17
17843511
17972422
-
ACACA
chr17
37084992
37406836
-
TAF4
chr20
61953469
62065810
-
MID1IP1
chrX
38801432
38806537
+
FBXO46
chr19
45710629
45730896
-
BICRA
chr19
47608196
47703277
+
CALR
chr19
12938578
12944489
+
ARHGDIA
chr17
81867721
81871378
-
UCP2
chr11
73974672
73983246
-
FKBP1A
chr20
1368978
1393172
-
SLC6A6
chr3
14402576
14489349
+
NFIX
chr19
12995608
13098796
+
ADGRL1
chr19
14147743
14206187
-
NID1
chr1
235975830
236065109
-
CAPZB
chr1
19338775
19485539
-
AGRN
chr1
1020120
1056118
+
AXL
chr19
41219223
41261766
+
MAFG
chr17
81918270
81927735
-
PKM
chr15
72199029
72231822
-
IGFBP5
chr2
216672105
216695549
-
MIGA2
chr9
129036621
129072082
+
ZMIZ1
chr10
79068966
79316528
+
PRRC2B
chr9
131373636
131500197
+
ACVR1B
chr12
51951699
51997078
+
DMWD
chr19
45782947
45792845
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000417
chr12
69644908
69656342
+
hsa_circ_0000642
chr15
80390757
80415142
+
hsa_circ_0000816
chr17
80521229
80526077
+
hsa_circ_0000643
chr15
80412669
80415142
+
hsa_circ_0000943
chr19
47421744
47440665
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC239868.1
chr1
149861271
149862504
+
AL035458.2
chr20
34234840
34281173
-
AL356488.2
chr1
109100193
109100619
+
NEAT1
chr11
65422774
65445540
+
NORAD
chr20
36045618
36051018
-
OIP5-AS1
chr15
41283990
41309737
+
STAG3L5P-PVRIG2P-PILRB
chr7
100336104
100367831
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.